New numbers coming out of the Drug Enforcement Administration New Orleans Division show just how much of the deadly drug, fentanyl, it’s agents seized in 2022.
) - The agency reported 501,761 fentanyl laced-fake prescription pills and 613 pounds of fentanyl powder were seized in those four states this past year.
The DEA estimated that could kill more than 20.2 million people. The DEA New Orleans Division said it’s enough to kill everyone in those four states it serves. In Alabama, the DEA said more than 23,000 fentanyl pills and close to 23 pounds of fentanyl powder were picked up in 2022. That’s 756,651 estimated deadly doses.
The DEA put the blame on two Mexican drug cartels that are quote “...primarily responsible for the fentanyl that is killing Americans today.” The DEA warned that these fentanyl pills are being made to look identical to real prescription meds like Xanax, Oxycontin and Percocet.Download the FOX10 Weather App. Get life-saving severe weather warnings and alerts for your location no matter where you are. Available free in the
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How Top Gun: Maverick Left 800 Hours On The Cutting Room FloorThe blockbuster hit TopGunMaverick actually left over 800 hours of footage on the cutting room floor before sending it off to theaters: 'It was quite honestly very overwhelming at times.'
Read more »
Sask. reaches new record for overdose deaths in 2022Preliminary data shows Saskatchewan had more overdose deaths in 2022 than any year previous, an increase from the record set in 2021.
Read more »
New Braunfels, San Antonio make list of hottest ZIP codes in U.S. in 2022New data from real estate company Opendoor shows New Braunfels and San Antonio were two of the hottest places to buy real estate in 2022.
Read more »
Avatar Generations Gameplay Trailer ReleasedFollowing the 2022 reveal of a new Avatar: The Last Airbender game called Avatar Generations, [...]
Read more »
Fresh from the biotech pipeline: fewer approvals, but biologics gain share - Nature Biotechnology2022 saw a 25% drop in new drug approvals and a less predictable regulator.
Read more »